baber/WOPTO huggingface dataset:
Patent MX-2017015678-A (MX)
Title: Thermally inhibited agglomerated starch.
Inventor: CHRISTOPHER LANE
IPC: A23L29/212
Filed: 2017-12-04
Abstract: Methods for preparing thermally inhibited starch agglomerates are disclosed. Thermally inhibited starch agglomerates prepared by this method provide a higher viscosity over thermally inhibited starches that are not agglomerated but are thermally inhibited in the same manner as the thermally inhibited starch agglomerates.
Patent MX-2018000346-A (MX)
Title: Seat supported airbag.
Inventor: DEAN M JARADI
IPC: B60R21/16
Filed: 2018-01-09
Abstract: A seating assembly for use in a vehicle includes a seat back and an airbag. The seat back has a bottom, a top, and a midpoint between the bottom and the top. The airbag is supported by the seat back and is inflatable to an inflated position. In the inflated position the airbag may extend from the top to a location between the midpoint and the bottom and define a cavity with an opening facing the bottom and away from the seat back.
Patent MX-2018003240-A (MX)
Title: Pre-heating and thermal control of work rolls in metal rolling processes and control systems thereof.
Inventor: DAVID ANTHONY GAENSBAUER
IPC: B21B37/32
Filed: 2016-09-21
Abstract: Systems and methods for using full-width hot sprays 118 to pre-heat rolling mills 100 prior to processing of metal sheet or plate are described herein. The hot sprays 118 may be individually controlled. Using hot sprays can allow the rolling mill 100 to reach operating temperature and achieve a desired thermal crown so that metal sheet or plate 102 may be processed immediately within tolerances for flatness and gauge accuracy. Pre-heating of rolling mills 100 can eliminate the need of the rolling mill 100 to operate in a transitional period of work roll heating and can increase efficiency by eliminating or reducing scrap material and mill downtime. Hot sprays 118 may also be incorporated with existing coolant systems to provide thermal control systems for rolling mills 100 with bi-directional temperature controls.
Patent MX-2018004661-A (MX)
Title: Antenna structure for exchanging wireless signals.
Inventor: IRWIN GERSZBERG
IPC: H01Q19/08
Filed: 2016-09-12
Abstract: Aspects of the subject disclosure may include, for example, an antenna structure that includes a feed point that facilitates coupling to a dielectric core that supplies electromagnetic waves to the feed point, and a dielectric antenna coupled to the feed point for receiving the electromagnetic waves, the dielectric antenna including an antenna lens that operates as an aperture of the dielectric antenna, the antenna lens having a structure that adjusts a propagation of the electromagnetic waves in the dielectric antenna to reduce a cross section of far-field wireless signals generated by the dielectric antenna. Other embodiments are disclosed.
Patent MX-2018004793-A (MX)
Title: Plasma treatment of filtration media for smoking articles.
Inventor: JEROME UTHURRY
IPC: A24D3/06
Filed: 2016-10-24
Abstract: A smoking article includes smokable material, a filter downstream of the smokable material, and a breakable capsule (80). The filter is plasma treated or has an increased surface energy relative to standard filter material. The breakable capsule (80) includes a core surrounded by a frangible shell. The core contains a liquid composition comprising a sensory-enhancing agent. The breakable capsule is positioned to cause the liquid composition to contact the filter material (32) when the shell is ruptured.
Patent MX-2018006603-A (MX)
Title: Method for manufacturing tin-plated copper terminal material.
Inventor: KIYOTAKA NAKAYA
IPC: C25D5/12
Filed: 2016-12-14
Abstract: The present invention is a method for manufacturing a tin-plated copper terminal material, which uses a copper or copper alloy substrate, for terminals to be pressure welded on the ends of electric wires made of aluminum wire and which is not susceptible to electric erosion and has excellent tin layer adhesiveness. The method comprises: a zinc nickel alloy layer-forming step for forming a zinc nickel alloy layer, in which the nickel content is 5 mass% to 50 mass%, on a substrate made of copper or copper alloy at a thickness of 0.1 µm to 5.0 µm; and a tin-plating step for forming a tin layer by performing tin-plating on the zinc nickel alloy layer. More preferably, after the tin-plating step, the method also comprises a diffusion step for diffusing the zinc of the zinc nickel alloy layer into the tin layer by maintaining at 40°C to 160°C for at least 30 minutes.
Patent MX-2018006701-A (MX)
Title: Preform with a concave bottom and an evolving thickness.
Inventor: CHRISTOPHE BUNEL
IPC: B29B11/14
Filed: 2016-11-17
Abstract: A preform (1) for a plastics container, which comprises :­ a rotationally symmetrical body (3) about a central axis (X), :­ an open neck which extends in continuation of the body (3) from an upper end of the latter, and :­ a bottom (7) which closes the body (3) starting from a lower end (8) of the latter, the bottom (7) being rotationally symmetrical about the central axis (X) and having a central concavity (9) and a protruding bulge (10) around this concavity (9), the bottom (7) having a thickness E, measured from an external face (17), that is variable in accordance with three different criteria respectively applied to three sections of the bottom, namely a central section [0; S1], an intermediate section [S1; S2] and a peripheral section [S2; L].
Patent MX-2018007852-A (MX)
Title: Indolinones compounds and their use in the treatment of fibrotic diseases.
Inventor: STEPHEN PAUL COLLINGWOOD
IPC: C07D209/34
Filed: 2016-12-23
Abstract: The present invention relates inter alia to a compound of formula (I) Wherein R1, R2, R3 and Z are as defined in the specification and to compositions comprising the same and to the use of the compounds and to compositions of the compounds in treatment, for example in the treatment of fibrotic diseases or interstitial lung diseases, in particular idiopathic pulmonary fibrosis.
Patent MX-2018009256-A (MX)
Title: Photochemically stable, non-leaching, bridged polysilsesquioxane based sunscreens.
Inventor: DOUGLAS A LOY
IPC: C01B33/12
Filed: 2017-01-30
Abstract: Bridged polysilsesquioxane based sunscreens prepared as nanoparticles via oil/water microemulsion polymerization, sol-gel polymerizations, or a modified Stober process. Minimized leaching and decreased levels of photo-degradation were achieved with covalent incorporation, with bridged incorporation necessary to ensure isolation of the sunscreen and any photo-products from skin. SPF values of were found to be comparable to existing commercial sunscreens. Furthermore the bridged polysilsesquioxane based sunscreens can be classified as broad-spectrum, and rate from moderate to superior in terms of UVA protective ability.
Patent MX-2018010052-A (MX)
Title: System and method for controlling asset-related actions via a blockchain.
Inventor: CRAIG STEVEN WRIGHT
IPC: G06Q20/38
Filed: 2017-02-14
Abstract: According to one perspective, the invention provides a technical arrangement to calculate, register and/or apportion costs and/or generate income in proportion to the current ownership of an asset. One or more embodiments also comprise a novel technique for generating cryptographic sub-keys. Thus, one benefit provided by the invention is that it allows the secure distribution of costs and income for an asset registered and maintained on the Blockchain. In turn, this increases the capability of such assets to meet the real-world needs of various entities such as the asset itself and investing parties. In one embodiment the invention provides a computer-implemented system for controlling a transfer made via a blockchain in respect of an asset, the system comprising an asset having a plurality of private cryptographic keys, each private key being associated with an owner of the asset; a registry comprising a plurality of public cryptographic keys wherein each public key corresponds to a private key in the asset's plurality of private keys, and is associated with a redeem script hash that can be identified within an unspent blockchain transaction; a smart contract comprising at least one rule relating to the automated generation of one or more blockchain transactions to enable a transfer to be made in respect of the asset; and a computing agent arranged to evaluate and/or execute the at least one rule of the smart contract. In some embodiments, a hierarchy of computing agents is managed by a master agent to carry out the asset related tasks defined in the smart contract. The master and subordinate agents communicate to execute discrete tasks.
Patent MX-2018011705-A (MX)
Title: Steroid hormone pharmaceutical composition.
Inventor: PETER H R PERSICANER
IPC: A61K31/565
Filed: 2017-03-30
Abstract: This disclosure provides a novel pharmaceutical composition for delivering steroid hormones to a patient in need thereof.
Patent MX-2018014123-A (MX)
Title: Processes for preparing phosphorodiamidate morpholino oligomers.
Inventor: BAO CAI
IPC: C07D265/30
Filed: 2017-06-30
Abstract: Provided herein are processes for preparing an oligomer (e.g., a morpholino oligomer). The synthetic processes described herein may be advantageous to scaling up oligomer synthesis while maintaining overall yield and purity of a synthesized oligomer.
Patent MX-2018015734-A (MX)
Title: 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors.
Inventor: JAN KEHLER
IPC: C07D471/04
Filed: 2017-06-30
Abstract: The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders.
Patent MX-2019002835-A (MX)
Title: Stabilized non-protein clostridial toxin compositions.
Inventor: MAURICE ABIAD
IPC: A61P17/00
Filed: 2017-09-13
Abstract: Pharmaceutical compositions that stabilize a Clostridial toxin active ingredient are described. The compositions can be liquid or solid compositions, and comprise a surfactant and an antioxidant. In some embodiments, the compositions comprise a surfactant selected from a poloxamer and a polysorbate; an antioxidant selected from methionine, N-acetyl cysteine, ethylenediaminetetraacetic acid and combinations thereof; and, optionally, a tonicity agent and/or a lyoprotector selected from, for example, trehalose and sucrose.
Patent MX-2019005985-A (MX)
Title: System and method for purifying liquid by reverse osmosis.
Inventor: DRISS STITOU
IPC: F04B9/123
Filed: 2017-11-22
Abstract: The invention relates to a system (100) for purifying a liquid, referred to as liquid to be treated (104), in particular salt water, comprising: a so-called treatment module (112), for treating the liquid to be treated (104) and for providing a so-called purified liquid as well as a so-called residual liquid; and a pressurisation means (102) for pressurising said liquid to be treated (104) in order to supply said treatment module (112), comprising: a so-called master cylinder (102M), provided to be driven by a so-called driving fluid (130;314), and at least one slave cylinder (102E), driven by said master cylinder (102M), provided to receive said liquid to be treated (104) and to supply same to said treatment module (112); characterised in that the section of said master cylinder (102M) is larger than the section of said at least one slave cylinder (102E) and in that it comprises a means for pre-pressurising the liquid to be treated (104). The invention also relates to a method for purifying liquid to be treated implementing the system (100) according to the invention.
Patent MX-2019006891-A (MX)
Title: On-board device for recharging an electric vehicle by conduction.
Inventor: JEAN-LUC HOURTANE
IPC: B60L53/14
Filed: 2019-06-12
Abstract: A device is electrically connected to first and second terminals of an energy collector and provided with first and second electrical contacts intended to be placed in contact, for the electrical supply of the energy collector, respectively with first and second conjugated electrical contacts of a supply device on the ground, in turn electrically connected to an electrical power source. The device has a mesh connecting the second electrical contact and an output terminal connected to the second terminal of the energy collector, the mesh having a diode inserted between the second electrical contact and the second terminal of the energy collector so as to avoid the circulation of a current toward the second terminal of the energy collector.
Patent MX-2019007090-A (MX)
Title: Laser-treated fabric.
Inventor: DHRUV AGARWAL
IPC: D06M10/04
Filed: 2017-12-14
Abstract: A laser-treated fabric including a body side and a face side has a plurality of pores located on at least some fibers on at least the body side of the fabric and at least one chemical additive embedded within or anchored to the plurality of pores. The pores have a pore size of from about 1 nm to about 20 m. Garments including the laser-treated fabric are also described. The fabric in the garment may be laser-treated such that the plurality of pores are located in discrete regions of the fabric. Methods for treating a fabric are also described. The chemical additive in the laser-treated fabrics is more durable than in non-laser-treated fabrics have a chemical additive applied on only the surface of the fabric.
Patent MX-2019007100-A (MX)
Title: Bicyclic thiazine and oxazine derivatives as beta-secretase inhibitors and methods of use.
Inventor: LIPING H PETTUS
IPC: C07D513/04
Filed: 2017-12-13
Abstract: The present disclosure provides a new class of compounds useful for the modulation of beta-secretase enzyme (BACE) activity. The compounds have a general Formula (I): (Formula (I)) wherein variables X, Y, R2, R3, R4, R5, R6, and n of Formula (I) are defined herein. This disclosure also provides pharmaceutical compositions comprising the compounds, and uses of the compounds and compositions for treatment of disorders and/or conditions related to Aß plaque formation and deposition, resulting from the biological activity of BACE. Such BACE mediated disorders include, for example, Alzheimer 's disease, cognitive deficits, cognitive impairments, and other central nervous system conditions.
Patent MX-2019008435-A (MX)
Title: Jak1 selective inhibitors.
Inventor: MATTI JUHANI LEPISTÖ
IPC: A61P17/14
Filed: 2018-01-16
Abstract: Disclosed herein are compounds of Formula (I), and pharmaceutically acceptable salts thereof, wherein R1-R8 have any of the meanings defined herein. Also disclosed are pharmaceutical compositions comprising compounds of Formula (I) and methods of using the same.
Patent MX-2019009463-A (MX)
Title: Methods and apparatus for low-pressure radiant energy processing of cannabis.
Inventor: CALEB JOSHUA EADES
IPC: C07C37/70
Filed: 2018-02-08
Abstract: Methods and apparatuses for reducing the bioburden of cannabis using low-pressure radiant energy processing. The present invention achieves sufficient microbial killing and/or adequate drying without impacting product quality (terpene loss, smell, color, texture, etc.) by appropriate determination and application of pressure(s) and radiant energy (e.g., microwave intensity).
Patent MX-2019010735-A (MX)
Title: Systems and methods for the targeted production of a therapeutic protein within a target cell.
Inventor: Matthew r scholz
IPC: C12P21/06
Filed: 2015-09-23
Abstract: Provided are nucleic acid-based expression constructs for the targeted production of a therapeutic protein within a cell that is associated with aging, disease, another condition. Also provided are vectors and systems for the delivery of those nucleic acid-based expression constructs as well as methods for using such nucleic acid-based expression constructs, vectors, and systems for reducing, preventing, and/or eliminating the growth and/or survival of an age-, disease-, or condition-associated cell and for the treatment of a disease or condition that is associated with an age, disease, or condition associated cell.
Patent MX-2019010954-A (MX)
Title: Glycoside blends.
Inventor: BRIAN D GUTHRIE
IPC: A23L2/60
Filed: 2013-06-05
Abstract: Sweetener compositions comprising particular glycoside blends are described in this paper. The glycioside blends comprise rebaudioside A, rebaudioside B, and/or rebaudioside D in various proportions. The sweetener composition can also include one or more bulking agents or other ingredients. The sweetener compositions can be used in foods and beverages.
Patent MX-2019013458-A (MX)
Title: Human-enzyme mediated depletion of homocysteine for treating patients with hyperhomocysteinemia and homocystinuria.
Inventor: EVERETT STONE
IPC: C12N9/88
Filed: 2018-05-11
Abstract: Methods and compositions relating to the engineering of an improved protein with homocyst(e)inase enzyme activity are described. For example, there are disclosed modified cystathionine-Y-lyase (CGL) enzymes comprising one or more amino acid substitutions and capable of degrading homocysteine. Furthermore, provided are compositions and methods for the treatment of homocystinuria or hyperhomocysteinemia with homocysteine depletion using the disclosed enzymes or nucleic acids.
Patent MX-2019013504-A (MX)
Title: Particles of water-soluble solids encapsulated in a composite matrix based on water-soluble polymers and the obtaining method thereof.
Inventor: NAVARRO GUAJARDO NOÉ BENJAMÍN
IPC: A61K9/70
Filed: 2019-11-12
Abstract: The present invention relates to water-soluble solid particles encapsulated in a matrix composed of water-soluble polymers obtained by a spray drying process. Said matrix consists of organic nanoparticles of non-water-soluble material dispersed in a partially or water-soluble polymer matrix for controlling the water absorption capacity, allowing a slow, gradual, controlled, and systematic release of the active agents, improving them by prolonging its action over time. Particularly, the present invention discloses systems of fertilizer particles encapsulated in matrices composed of water-soluble polymers, which confer higher stability to the fertilizer and the characteristic of slow-release.
Patent MX-2019014105-A (MX)
Title: Biopharmaceutical compositions and related methods.
Inventor: STEVEN GRANT
IPC: C07K16/24
Filed: 2018-05-24
Abstract: The present disclosure relates to antigen binding compositions, including antibodies, for treating interleukin 5 (IL-5) mediated diseases, and related methods. IL-5 is a secreted protein. IL- 5 plays a role in a number of different diseases such as asthma, mild asthma, moderate asthma, severe asthma, mild eosinophilic asthma, moderate eosinophilic asthma, severe eosinophilic asthma, uncontrolled eosinophilic asthma, eosinophilic asthma, sub-eosinophilic asthma, chronic obstructive pulmonary disease, eosinophilic granulomatosis with polyangiitis, hypereosinophilic syndrome, nasal polyposis, bullous pemphigoid, eosinophilic esophagitis, atopic dermatitis, moderate atopic dermatitis and severe atopic dermatitis. The disclosed compositions are suitable for treating these serious IL-5 mediated diseases.
Patent MX-2020003425-A (MX)
Title: Treatment of inflammatory disorders.
Inventor: MACDONALD SUSAN
IPC: C07D487/00
Filed: 2018-10-10
Abstract: EMPTY
Patent MX-2020004521-A (MX)
Title: Endophytic microbial seed treatment formulations and methods related thereto for improved plant performance.
Inventor: CADLE-DAVIDSON MOLLY
IPC: A01P21/00
Filed: 2018-10-25
Abstract: This invention describes discovery and development of a biological system of plant growth promotion and environmental improvement by carbon sequestration and/or nitrogen utilization by application of a microbial agent, e.g., a highly effective strain of T. viride, particularly strains NRRL B-50520 and/or K5. This strain outperforms the best current strains of Trichoderma used for this purpose available commercially. The highly active products also are expected to increase plant productivity and improve quality of fruits, vegetables, flowers or other plant products. The invention also describes and demonstrates that strain combinations including Bacillus amyloliquifaciens AS2 or AS35 as well as disclosed metabolites, promote plant growth. This is true across monocots and dicots, seed treatments and foliar sprays. In the field plant height, shoot weight, root weight, and photosynthesis (Spad meter readings) were all increased in comparison to the untreated control as well as the leading biological seed treatments. The invention also describes metabolite utilization for enhancing plant growth.
Patent MX-2020006475-A (MX)
Title: Blackened optical component without fluorescence.
Inventor: VITOL ELINA A
IPC: C23C22/83
Filed: 2018-12-20
Abstract: An optical component may be optically blackened so that the surface of the component is not reflective when light impinges upon the surface. In some examples, a method of blackening involves exposing a surface of the optical component that defines an optical pathway to an optical blackening composition for a period of time effective to optically blacken the surface. The optical blackening composition may be configured so that the resulting optically blackened optical pathway is non-fluorescing when exposed to ultraviolet light. In some examples, the optical blackening composition comprises selenous acid and is devoid of organic molecules.
Patent MX-2020006512-A (MX)
Title: Antiparasitic pour-on compositions.
Inventor: FREEHAUF KEITH
IPC: A61K9/00
Filed: 2018-12-21
Abstract: Liquid veterinary pour-on or spot-on composition comprising at least one isoxazoline compound of formula (I) and a pharmaceutically acceptable carrier comprising at least one dermal penetration 5 enhancer comprising menthol and a solvent system comprising a pyrrolidone solvent are disclosed. Methods for using and administering such preparation in the prevention and control of parasite infestations in livestock animals are also disclosed.
Patent MX-2020007124-A (MX)
Title: Pharmaceutical formulation for mucosal administration of sensitive materials, substances, or mixtures and obtaining process thereof.
Inventor: QUINTANAR GUERRERO DAVID
IPC: A61K9/20
Filed: 2020-07-13
Abstract: The present invention relates to the preparation and process for obtaining a powder that contains one or more sensitive materials and substances conferring protection against the gastrointestinal environment (acidity and enzymatic attack), allowing its oral administration. The said formulation consists of generating core particles containing the sensitive material and the selected excipients that provide stability by the spray-drying technique and coating the core particles with an enteric or bioadhesive layer.
Patent MX-2020010062-A (MX)
Title: Methods for curtain coating substrates.
Inventor: PUJARI SASWATI
IPC: B05D1/34
Filed: 2019-01-28
Abstract: Methods of curtain coating substrates are disclosed. In some embodiments, the methods include applying two or more liquid layers simultaneously to a substrate, wherein the multiple layers include a bottom liquid layer comprising a shear thinning liquid, and another liquid layer comprising a viscoelastic liquid. In some embodiments, the disclosed methods include formulating a bottom layer liquid comprising a shear thinning liquid, formulating another layer liquid comprising a viscoelastic liquid, pumping the bottom layer liquid and the other layer liquid through coating dies simultaneously and onto a moving substrate such that the bottom layer liquid impinges on the substrate thereby forming a bottom layer, and the other layer liquid forms another liquid layer above the bottom liquid layer. The inclusion of a bottom liquid layer comprising a shear thinning liquid and other layer comprising a viscoelastic liquid provides for enlargement of the curtain coating window.